Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1985 Nov;50(2):354–357. doi: 10.1128/iai.50.2.354-357.1985

Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

L Choromanski, R E Kuhn
PMCID: PMC261956  PMID: 3932205

Abstract

Mice infected with Trypanosoma cruzi develop an early and profound immunosuppression of responses to heterologous antigens. Recently it has been demonstrated that this immunosuppression is linked, in part, to deficiency in the production of interleukin 2 (IL-2), and that the addition of IL-2 to cultures of normally unresponsive spleen cells from infected mice will restore responsiveness to sheep erythrocytes (SRBC) and enhance parasite-specific immune responses. In the present study, the effect of administration of ultrapure or recombinant IL-2 on immune responses to SRBC and parasite-specific responses in vivo was examined. It was found that a single injection of 1,500 U of IL-2 provided at the same time as SRBC more than doubled the number of direct plaque-forming cells to SRBC and that multiple injections of 1,500 U of IL-2 were no more restorative than a single injection. Anti-SRBC responses of normal mice were unaffected by injection of IL-2. Single or multiple injections of recombinant human IL-2, with and without gelatin, into highly susceptible C3H(He) mice induced greater parasite-specific immunity as reflected by significantly reduced levels of parasitemia and increased longevity. Three injections of 1,500 U each of recombinant human IL-2 on days 10, 14, and 18 was found to be the most efficacious in reducing parasitemia and increasing longevity. Injection of IL-2 with gelatin did not enhance the effect of IL-2 alone.

Full text

PDF
354

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cunningham D. S., Kuhn R. E., Tarleton R. L., Dunn R. S. Trypanosoma cruzi: effect on B-cell-responsive and -responding clones. Exp Parasitol. 1981 Apr;51(2):257–268. doi: 10.1016/0014-4894(81)90114-4. [DOI] [PubMed] [Google Scholar]
  2. Cunningham D. S., Kuhn R. E. Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens. J Parasitol. 1980 Feb;66(1):16–27. [PubMed] [Google Scholar]
  3. Donohue J. H., Rosenberg S. A. The fate of interleukin-2 after in vivo administration. J Immunol. 1983 May;130(5):2203–2208. [PubMed] [Google Scholar]
  4. Donohue J. H., Rosenstein M., Chang A. E., Lotze M. T., Robb R. J., Rosenberg S. A. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. J Immunol. 1984 Apr;132(4):2123–2128. [PubMed] [Google Scholar]
  5. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  6. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3466–3469. doi: 10.1073/pnas.80.11.3466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hefeneider S. H., Conlon P. J., Henney C. S., Gillis S. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol. 1983 Jan;130(1):222–227. [PubMed] [Google Scholar]
  8. Jerne N. K., Henry C., Nordin A. A., Fuji H., Koros A. M., Lefkovits I. Plaque forming cells: methodology and theory. Transplant Rev. 1974;18:130–191. doi: 10.1111/j.1600-065x.1974.tb01588.x. [DOI] [PubMed] [Google Scholar]
  9. Kierszenbaum F. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J Immunol. 1982 Nov;129(5):2202–2205. [PubMed] [Google Scholar]
  10. Kuhn R. E., Murnane J. E. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro. Exp Parasitol. 1977 Feb;41(1):66–73. doi: 10.1016/0014-4894(77)90130-8. [DOI] [PubMed] [Google Scholar]
  11. Kuhn R. E., Vaughn R. T., Herbst G. A. The effect of BCG on the course of experimental Chagas' disease in mice. Int J Parasitol. 1975 Oct;5(5):557–560. doi: 10.1016/0020-7519(75)90049-1. [DOI] [PubMed] [Google Scholar]
  12. Mertelsmann R., Welte K., Sternberg C., O'Reilly R., Moore M. A., Clarkson B. D., Oettgen H. F. Treatment of immunodeficiency with interleukin-2: initial exploration. J Biol Response Mod. 1984 Oct;3(5):483–490. [PubMed] [Google Scholar]
  13. Ramos C., Schädtler-Siwon I., Ortiz-Ortiz L. Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice. J Immunol. 1979 Apr;122(4):1243–1247. [PubMed] [Google Scholar]
  14. Reed S. G., Inverso J. A., Roters S. B. Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2. J Immunol. 1984 Sep;133(3):1558–1563. [PubMed] [Google Scholar]
  15. Reed S. G., Inverso J. A., Roters S. B. Suppressed antibody responses to sheep erythrocytes in mice with chronic Trypanosoma cruzi infections are restored with interleukin 2. J Immunol. 1984 Dec;133(6):3333–3337. [PubMed] [Google Scholar]
  16. Reed S. G., Roters S. B., Goidl E. A. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J Immunol. 1983 Oct;131(4):1978–1982. [PubMed] [Google Scholar]
  17. Smith K. A. Interleukin 2. Annu Rev Immunol. 1984;2:319–333. doi: 10.1146/annurev.iy.02.040184.001535. [DOI] [PubMed] [Google Scholar]
  18. Tarleton R. L., Kuhn R. E. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response. Cell Immunol. 1983 Sep;80(2):392–404. doi: 10.1016/0008-8749(83)90126-0. [DOI] [PubMed] [Google Scholar]
  19. Tarleton R. L., Kuhn R. E. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. J Immunol. 1984 Sep;133(3):1570–1575. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES